Skip to content
Cryptos: 553Market Cap: $2.87T 1.3%24h Vol: $129.14BDominance: BTC 58.1% ETH 10.5%
Open Tradzy

New low · Taiwan stocks

Caliway Biopharmaceuticals Co., Ltd. (6919) closes at a 52-week low of TWD 75.00

Its third new 52-week low in 5 sessions. Down 8.1% over 20 sessions.

Published 19 October 2026 · Written from Tradzy's price and volume data

Close
TWD 75.00
On the day
−2.5%
Volume
0.2× average
vs 52-week high
−59.0%

Caliway Biopharmaceuticals Co., Ltd. closing prices

TWD 80.00TWD 100.00TWD 120.00Jun '26Jul '26Jul '26Aug '26Sep '26Oct '26TWD 75.00

The last 90 closes up to 19 October 2026. The live chart is on the 6919 page.

What happened

Caliway Biopharmaceuticals Co., Ltd. (6919) closed at TWD 75.00 on 19 October 2026, down 2.5% from TWD 76.90 the session before.

It is the third new low in the last 5 sessions. Over 5 sessions the price is down 2.8%, and over 20 sessions it is down 8.1%.

That close is below every close of the past year. The previous lowest was TWD 75.30 on 15 Oct 2026, and the new close is 0.4% under it.

Trading was light: volume was 23% of its recent average.

Across the 20 TAIWAN stocks we track, 3 closed higher and 16 closed lower that day, with a median change of −1.13%. 6919's change was −2.5%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeTWD 76.90
CloseTWD 75.00
Change on the day−2.47%
Change over 5 sessions−2.85%
Change over 20 sessions−8.09%
Volume887,929
Average volume, up to 20 sessions before3.85 Million
Volume against that average0.2 times
Highest close in the past yearTWD 183.00 (4 Dec 2025)
Lowest close in the past yearTWD 75.30 (15 Oct 2026)

The full chart and history are on Caliway Biopharmaceuticals Co., Ltd. (6919). More from this market: TAIWAN news today.

More TAIWAN moves on 19 October 2026

Want a plan for 6919? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.